Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Kawasaki Disease:

Kawasaki disease: epidemiology and the lessons from it. Nakamura Y et al. Int J Rheum Dis. (2018)

The genetics of Kawasaki disease. Onouchi Y et al. Int J Rheum Dis. (2018)

Kawasaki disease: etiopathogenesis and novel treatment strategies. Agarwal S et al. Expert Rev Clin Immunol. (2017)

Search results

Items: 1 to 20 of 11505

1.

Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.

Yamaguchi M, Suzuki R, Miyazaki K, Amaki J, Takizawa J, Sekiguchi N, Kinoshita S, Tomita N, Wada H, Kobayashi Y, Niitsu N, Ando T, Maeda T, Saito B, Matsuoka H, Sakai R, Kubota N, Masaki Y, Kameoka Y, Asano N, Oguchi M, Katayama N.

Ann Hematol. 2019 Apr 19. doi: 10.1007/s00277-019-03689-9. [Epub ahead of print]

PMID:
31001658
2.

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease.

Song MS.

Korean J Pediatr. 2019 Apr;62(4):119-123. doi: 10.3345/kjp.2019.00150. Epub 2019 Mar 15.

PMID:
30999718
3.

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Bettiol A, Lopalco G, Emmi G, Cantarini L, Urban ML, Vitale A, Denora N, Lopalco A, Cutrignelli A, Lopedota A, Venerito V, Fornaro M, Vannacci A, Rigante D, Cimaz R, Iannone F.

Int J Mol Sci. 2019 Apr 17;20(8). pii: E1898. doi: 10.3390/ijms20081898. Review.

PMID:
30999610
4.

Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic.

Uehara A, Kita Y, Sumi H, Shibagaki Y.

Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2608-18. [Epub ahead of print]

5.

Clinical Impact of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve on Japanese Population in the ADVANCE Registry.

Shiono Y, Matsuo H, Kawasaki T, Amano T, Kitabata H, Kubo T, Morino Y, Yoda S, Sakamoto T, Ito H, Shite J, Otake H, Tanaka N, Terashima M, Kadota K, Patel MR, Nieman K, Rogers C, Nørgaard BL, Bax JJ, Raff GL, Chinnaiyan KM, Berman DS, Fairbairn TA, Hurwitz Koweek LM, Leipsic J, Akasaka T.

Circ J. 2019 Apr 18. doi: 10.1253/circj.CJ-18-1269. [Epub ahead of print]

6.

Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody.

Makita N, Ando T, Sato J, Manaka K, Mitani K, Kikuchi Y, Niwa T, Ootaki M, Takeba Y, Matsumoto N, Kawakami A, Ogawa T, Nangaku M, Iiri T.

JCI Insight. 2019 Apr 18;4(8). pii: 126449. doi: 10.1172/jci.insight.126449. eCollection 2019 Apr 18.

7.

The reduced folate carrier: an entry receptor for a novel feline leukemia virus variant.

Miyake A, Kawasaki J, Ngo H, Makundi I, Muto Y, Khan AH, Smith DJ, Nishigaki K.

J Virol. 2019 Apr 17. pii: JVI.00269-19. doi: 10.1128/JVI.00269-19. [Epub ahead of print]

PMID:
30996094
8.

TNF and IL-1 Play Essential but Temporally Distinct Roles in Driving Cardiac Inflammation in a Murine Model of Kawasaki Disease.

Stock AT, Jama HA, Hansen JA, Wicks IP.

J Immunol. 2019 Apr 17. pii: ji1801593. doi: 10.4049/jimmunol.1801593. [Epub ahead of print]

PMID:
30996002
9.

Endoscopic diagnosis and treatment of ulcerative colitis-associated neoplasia.

Oka S, Uraoka T, Watanabe K, Hata K, Kawasaki K, Mizuno K, Misawa M, Hosoe N, Moriyama T, Kawachi H.

Dig Endosc. 2019 Apr;31 Suppl 1:26-30. doi: 10.1111/den.13373. No abstract available.

PMID:
30994223
10.

Involvement of cortical dysfunction in frequent falls in patients with Parkinson's disease.

Otomune H, Mihara M, Hattori N, Fujimoto H, Kajiyama Y, Konaka K, Mitani Y, Watanabe Y, Mochizuki H.

Parkinsonism Relat Disord. 2019 Apr 11. pii: S1353-8020(19)30202-0. doi: 10.1016/j.parkreldis.2019.04.007. [Epub ahead of print]

PMID:
30992233
11.

Vascular repair and anti-inflammatory effects of soluble epoxide hydrolase inhibitor.

Dai N, Zhao C, Kong Q, Li D, Cai Z, Wang M.

Exp Ther Med. 2019 May;17(5):3580-3588. doi: 10.3892/etm.2019.7396. Epub 2019 Mar 13.

12.

Anti-IL-10 antibody in systemic lupus erythematosus.

Uchida M, Ooka S, Goto Y, Suzuki K, Fujimoto H, Ishimori K, Matsushita H, Takakuwa Y, Kawahata K.

Open Access Rheumatol. 2019 Mar 26;11:61-65. doi: 10.2147/OARRR.S191953. eCollection 2019.

13.

Influenza A (H1N1) pdm09 virus infection in a patient with incomplete Kawasaki disease: A case report.

Wang J, Sun F, Deng HL, Liu RQ.

Medicine (Baltimore). 2019 Apr;98(15):e15009. doi: 10.1097/MD.0000000000015009.

14.

Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study.

Huang YH, Lin KM, Ho SC, Yan JH, Lo MH, Kuo HC.

Front Pediatr. 2019 Mar 29;7:121. doi: 10.3389/fped.2019.00121. eCollection 2019.

15.

Vitronectins produced by human cirrhotic liver and CCl4-treated rats differ in their glycosylation pattern and tissue remodeling activity.

Date K, Suzuki R, Oda-Tamai S, Ogawa H.

FEBS Open Bio. 2019 Mar 18;9(4):755-768. doi: 10.1002/2211-5463.12616. eCollection 2019 Apr.

16.

The rash with maculopapules and fever in children.

Muzumdar S, Rothe MJ, Grant-Kels JM.

Clin Dermatol. 2019 Mar - Apr;37(2):119-128. doi: 10.1016/j.clindermatol.2018.12.005. Epub 2018 Dec 5.

PMID:
30981292
17.

Seasonality differs by IVIG responsiveness in patients with Kawasaki disease.

Kido S, Ae R, Kosami K, Matsubara Y, Makino N, Sasahara T, Kuwabara M, Aoyama Y, Yashiro M, Yanagawa H, Nakamura Y.

Pediatr Int. 2019 Apr 12. doi: 10.1111/ped.13863. [Epub ahead of print]

PMID:
30980447
18.

Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.

Kawasaki M, Echiverri C, Raymond L, Cadena E, Reside E, Gler MT, Oda T, Ito R, Higashiyama R, Katsuragi K, Liu Y.

PLoS Med. 2019 Apr 12;16(4):e1002780. doi: 10.1371/journal.pmed.1002780. eCollection 2019 Apr.

19.

Periungual dryness without resultant desquamation in a child with kawasaki disease: a new clinical finding?

Gupta A, Singh S.

Eur J Rheumatol. 2019 Mar 10. doi: 10.5152/eurjrheum.2019.19001. [Epub ahead of print] No abstract available.

PMID:
30978161
20.

The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Naldemedine.

Fukumura K, Yamada T, Yokota T, Kawasaki A.

Clin Pharmacol Drug Dev. 2019 Apr 12. doi: 10.1002/cpdd.690. [Epub ahead of print]

PMID:
30977959

Supplemental Content

Loading ...
Support Center